Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioNeutra Global Corp V.BGA

Alternate Symbol(s):  BGACF

BioNeutra Global Corporation, through its subsidiaries, is involved in the research, development, production and commercialization of ingredients for nutraceutical, functional and mainstream foods and beverages, with a focus on oligosaccharides. The Company’s lead product, VitaFiber IMO, is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. It produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops, including tapioca, field pea or corn into the functional health molecules of isomalto-oligosaccharide. VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. The Company’s customers include a mix of small and medium enterprises.


TSXV:BGA - Post by User

Comment by mjh9413on Feb 04, 2021 11:39pm
339 Views
Post# 32481109

RE:RE:Boom!

RE:RE:Boom! Several things to put me off being longterm holder, one the balance sheet (made real bad with bankcruptcy of major coy 2019 I think), plus erratic revenue pergormance (but they have been reducing costs), another is 73% of sales to 4 clients (but this better than year ago and with no suspected major credit risks at last report), plus its reference to small/medium sized businesses being clients with nod of sorts to 'majors', and the supply risk for ingredients. Still, I think there are lots of stocks in 20c range that are riskier than this one.
<< Previous
Bullboard Posts